Latest News of IMV
Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?
By Yahoo! Finance |
4 weeks ago
Immunovant's fair value estimate is 19% higher than its analyst price target. Using a Discounted Cash Flow model, the intrinsic value of the company is calculated at US$8.5b, showing a 46% discount to...
ZimVie Inc. (ZIMV) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
2 months ago
ZimVie Inc. and its subsidiaries focus on developing and marketing products for treating spine pathologies and dental procedures globally. With two segments, Dental and Spine, they offer a range of de...